Literature DB >> 13539215

The metabolism of D-ribose in man.

S SEGAL, J FOLEY.   

Abstract

Entities:  

Keywords:  RIBOSE/metabolism

Mesh：

Substances：

Year:  1958        PMID： 13539215      PMCID： PMC293144          DOI： 10.1172/JCI103658

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  48 in total

1.  The L-xylulose-xylitol enzyme and other polyol dehydrogenases of guinea pig liver mitochondria.

Authors:  S HOLLMANN; O TOUSTER
Journal:  J Biol Chem       Date:  1957-03       Impact factor: 5.157

2.  Biosynthesis of the purines. VIII. Enzymatic synthesis and utilization of alpha-5-phosphoribosylpyrophosphate.

Authors:  C N REMY; W T REMY; J M BUCHANAN
Journal:  J Biol Chem       Date:  1955-12       Impact factor: 5.157

3.  Intermediary purine metabolism and the metabolic defects of gout.

Authors:  J B WYNGAARDEN
Journal:  Metabolism       Date:  1957-05       Impact factor: 8.694

4.  The enzymatic reaction between ribose 1-phosphate and glucose 1, 6-diphosphate.

Authors:  H KLENOW; R EMBERLAND
Journal:  Arch Biochem Biophys       Date:  1955-10       Impact factor: 4.013

5.  Significance of alternate pathways in the metabolism of glucose.

Authors:  H G WOOD
Journal:  Physiol Rev       Date:  1955-10       Impact factor: 37.312

6.  Mechanism of insulin action.

Authors:  D R DRURY; A N WICK
Journal:  Diabetes       Date:  1955 May-Jun       Impact factor: 9.461

7.  Carbohydrate metabolism.

Authors:  B L HORECKER; A H MEHLER
Journal:  Annu Rev Biochem       Date:  1955       Impact factor: 23.643

8.  Some properties of the phosphoribomutase reaction.

Authors:  H KLENOW
Journal:  Arch Biochem Biophys       Date:  1953-09       Impact factor: 4.013

9.  Nucleotide metabolism. II. Chromatographic separation of acid-soluble nucleotides.

Authors:  R B HURLBERT; H SCHMITZ; A F BRUMM; V R POTTER
Journal:  J Biol Chem       Date:  1954-07       Impact factor: 5.157

10.  Blood pyruvic acid response to intravenous glucose or insulin in the normal and in patients with liver disease and with diabetes mellitus.

Authors:  D S AMATUZIO; N SHRIFTER; F L STUTZMAN; S NESBITT
Journal:  J Clin Invest       Date:  1952-08       Impact factor: 14.808
View more
  16 in total

1.  The metabolism of variously C14-labeled glucose in man and an estimation of the extent of glucose metabolism by the hexose monophosphate pathway.

Authors:  S SEGAL; M BERMAN; A BLAIR
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

2.  The metabolic fate of C14 labeled pentoses in man.

Authors:  S SEGAL; J B FOLEY
Journal:  J Clin Invest       Date:  1959-02       Impact factor: 14.808

3.  SOME OBSERVATIONS ON THE METABOLISM OF D-GALACTOSE IN NORMAL MAN.

Authors:  S Segal; A Blair
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

4.  [Influence of ribose on 2,3-diphosphoglycerate concentrations in human erythrocytes].

Authors:  C Petrich; U Göbel; U Delvos
Journal:  Blut       Date:  1975-03

5.  Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.

Authors:  N Zöllner; S Reiter; M Gross; D Pongratz; C D Reimers; K Gerbitz; I Paetzke; T Deufel; G Hübner
Journal:  Klin Wochenschr       Date:  1986-12-15

6.  Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency.

Authors:  M Gross; S Reiter; N Zöllner
Journal:  Klin Wochenschr       Date:  1989-12-04

7.  Serum levels of glucose, insulin, and C-peptide during long-term D-ribose administration in man.

Authors:  M Gross; N Zöllner
Journal:  Klin Wochenschr       Date:  1991-01-04

8.  End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen.

Authors:  D R Sell; V M Monnier
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

9.  Pentose pathway in human liver.

Authors:  I Magnusson; V Chandramouli; W C Schumann; K Kumaran; J Wahren; B R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  D-ribose therapy in four Polish patients with adenylosuccinate lyase deficiency: absence of positive effect.

Authors:  A Jurecka; A Tylki-Szymanska; M Zikanova; J Krijt; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-12       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.